The Gerson Institute - Alternative Cancer Treatment
Links shared publicly online about this topic.
- 1,255total visits
The Gerson Institute - Alternative Cancer Treatment
View full resource at gerson.org
Tags: Pancreatic Disease, Cancer, Pancreatic Cancer, Parenting, Preventing, Education
Most Recently Shared on April 8, 2010 at 3:31 pm By:
Dad is educating himself about healing options by talking w a #Pancreatic #Cancer Survivor who used the #Gerson method. http://ow.ly/1w4VV
Identifying A Molecular-Based Treatment For A Viral Skin Cancer
medicalnewstoday.com — “Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a molecul” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2012 at 7:05 am By:
Identifying A Molecular-Based Treatment For A Viral Skin Cancer http://t.co/reDzqgWe #viruses #bacteria
PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue
news-medical.net — “Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in th” View full resource at news-medical.net
Most Recently Shared on May 5, 2012 at 12:37 pm By:
Oncology News: PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue: Lung can... http://t.co/2fLg0VAG
New genetic pathway influences spread of cancer cells
news-medical.net — “In a new study from Lawson Health Research Institute, Dr. Joseph Torchia has identified a new genetic pathway influencing the spread of cancer cells. The discovery of this mechanism could lead to new avenues for treatment.” View full resource at news-medical.net
Most Recently Shared on May 4, 2012 at 12:33 pm By:
Oncology News: New genetic pathway influences spread of cancer cells: In a new study from Lawson Health Research... http://t.co/DyCRCHSb
Hormone-receptor-positive cancer management study - National Cancer Institute
cancer.gov — “American and Spanish researchers, led by scientists from the University of North Carolina, Chapel Hill, have found potential ways for doctors to improve the treatment of hormone receptor-positive breast cancer even if they lack access to costly multi-gene” View full resource at cancer.gov
Most Recently Shared on May 3, 2012 at 11:00 pm By:
Study led by @UNC_Lineberger measures progesterone receptor expression 2 improve hormone-receptor-pos #cancer mgmnt http://t.co/vTp80jLP
New findings at European breast cancer conference - National Cancer Institute
cancer.gov — “An experimental model of breast cancer has yielded exciting new insights into why some breast cancers become resistant to endocrine therapies such as tamoxifen, say researchers from the Hospital of Prato, Italy, and the Breast Center at Baylor College of” View full resource at cancer.gov
Most Recently Shared on May 3, 2012 at 9:30 pm By:
Researchers at @BCMHouston present findings on treatment resistant #breast #cancer http://t.co/9GhK7kCQ
Pitt study of ultrasound-guided axillary node biopsy - National Cancer Institute
cancer.gov — “Contrary to a trend in treatment, breast cancer patients with suspicious lymph nodes should have an ultrasound-guided axillary node biopsy, and if that biopsy is positive these patients should undergo an axillary dissection, a new study shows. The study,” View full resource at cancer.gov
Most Recently Shared on May 3, 2012 at 9:00 pm By:
Study by #PITT finds #breast #cancer patients w/ positive ultrasound guided axillary node biopsy need dissection http://t.co/QboQ3tO7
Combination of new prostate cancer drugs can extend life for men
news-medical.net — “Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length of time they benefit, research led by The Institute of Cancer Research (ICR) has shown.” View full resource at news-medical.net
Most Recently Shared on May 2, 2012 at 10:07 am By:
Combination of new prostate cancer drugs can extend life for men: Combing two new prostate cancer drugs could in... http://t.co/ZXZktfuC
New form and function of a key protein - National Cancer Institute
cancer.gov — “Research led by St. Jude Children’s Research Hospital investigators suggests that safeguarding cell survival and maintaining a balanced immune system is just the start of the myeloid cell leukemia sequence 1 (MCL1) protein’s work. Nearly 20 years after MC” View full resource at cancer.gov
Most Recently Shared on May 1, 2012 at 7:36 pm By:
Scientists at @StJude discover new form & function of a key protein that may provide a novel #cancer treatment target http://t.co/22W3HOTY
Found in Translation: Finding Better Cancer Therapies -- Faster - DukeHealth.org
dukehealth.org — “With a bold strategy to spark innovative ideas and bring them into practice, Duke Cancer Institute is finding ways to bring new cancer therapies to patients faster.” View full resource at dukehealth.org
Most Recently Shared on April 23, 2012 at 5:40 pm By:
Duke's translational research program helps to bring cancer treatments from the lab to the clinic http://t.co/HvuOheaH
Dr. Dunleavy Discusses Treatment Options for PMBL
onclive.com — “Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses Treatment Options for Primary Mediastinal B Cell Lymphoma” View full resource at onclive.com
Most Recently Shared on April 16, 2012 at 4:47 pm By:
Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses Treatment Options for PMBL http://t.co/MhbpZoBG #OncLiveTV
Eisai breast cancer drug still viewed as not cost effective by NICE - Pharmaceutical and Biotechnology News - Pharma Letter
thepharmaletter.com — “In a third rejection, the UK drug watchdog the National Institute for Health and clinical Excellence (NICE) has issued new guidance not recommending Halaven (eribulin), from Japanese drug major Eisai (TYO: 4523), for the treatment of locally advanced or m” View full resource at thepharmaletter.com
Most Recently Shared on April 3, 2012 at 12:13 pm By:
Even w/discount MT @ThePharmaLetter: NICE still views Eisai breast cancer drug Halaven as not cost effective http://t.co/Bkd28AWx #pharma
Investigational targeted drug induces responses in aggressive lymphomas, April 2, 2012 News Release - National Institutes of Health (NIH)
nih.gov — “Preliminary results from clinical trials in a subtype of lymphoma show that for a number of patients whose disease was not cured by other treatments, the drug ibrutinib can provide significant anti-cancer responses with modest side effects. These results were presented as part of the opening plenary session at the American Association of Cancer Research (AACR) Annual Meeting 2012 on April 1 by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and coll” View full resource at nih.gov
Most Recently Shared on April 2, 2012 at 1:16 pm By:
News: Investigational targeted drug induces responses in aggressive lymphomas http://t.co/k15ySoFZ
Treating Cancer as a Chronic Disease
newswise.com — “New research from the Technion-Israel Institute of Technology and the Rambam Medical Center could someday lead to treatments that transform cancer from a lethal disease to a chronic, manageable one, similar to AIDS.” View full resource at newswise.com
Most Recently Shared on March 29, 2012 at 9:57 pm By:
#health news: Treating Cancer as a Chronic Disease http://t.co/hDCuVTi3
Treating Cancer as a Chronic Disease
newswise.com — “New research from the Technion-Israel Institute of Technology and the Rambam Medical Center could someday lead to treatments that transform cancer from a lethal disease to a chronic, manageable one, similar to AIDS.” View full resource at newswise.com
Most Recently Shared on March 29, 2012 at 9:33 pm By:
Treating Cancer as a Chronic Disease
newswise.com — “New research from the Technion-Israel Institute of Technology and the Rambam Medical Center could someday lead to treatments that transform cancer from a lethal disease to a chronic, manageable one, similar to AIDS.” View full resource at newswise.com
Most Recently Shared on March 29, 2012 at 8:55 pm By:
Treating Cancer as a Chronic Disease: New research from the Technion-Israel Institute of Technology and ... http://t.co/I23wIPgp #cancer
Advertisement

